Atherectomy Devices Market Report by Product Type, Application, End User, Countries and Companies Analysis 2026-2034

Global Atherectomy Devices Market Size and Forecast 2026-2034

Atherectomy Devices Market is expected to witness significant growth over the forecast period, driven by the rising prevalence of peripheral artery disease (PAD), increasing adoption of minimally invasive procedures, and continuous technological advancements in cardiovascular treatment devices. The market will grow from US$ 1.05 Billion in 2025 to US$ 1.58 Billion in 2034, at a Compound Annual Growth Rate (CAGR) of 4.62% from 2026 to 2034. Growing geriatric populations, expanding healthcare infrastructure, and increasing awareness regarding early vascular disease treatment are further supporting market expansion worldwide.

Global Atherectomy Devices Market Outlooks

Atherectomy devices are specialized medical instruments used to remove plaque buildup from blood vessels, particularly arteries affected by peripheral artery disease (PAD) and coronary artery disease (CAD). These devices help restore normal blood flow by cutting, shaving, sanding, or vaporizing fatty deposits inside the arteries. Atherectomy procedures are considered minimally invasive and are commonly performed in hospitals and cardiovascular centers as an alternative to open surgery. There are several types of atherectomy devices, including directional, rotational, orbital, and laser atherectomy systems, each designed for specific vascular conditions.

The worldwide popularity of atherectomy devices has increased significantly due to the rising prevalence of cardiovascular diseases, diabetes, obesity, and aging populations. The growing demand for minimally invasive treatments, shorter recovery times, and improved patient outcomes are major factors driving market growth. In addition, technological advancements in catheter-based therapies and the expansion of healthcare infrastructure in emerging economies are further boosting the adoption of atherectomy devices across global healthcare systems.

Number of People with Diabetes Worldwide and by IDF Region (Age 20-79), 2024-2050

Region 2024 (Million) 2050 (Million) % Increase (2024-2050)

World 588.7 852.5 45%

Africa (AFR) 24.6 59.5 142%

Europe (EUR) 65.6 72.4 10%

Middle East & North Africa (MENA) 84.7 162.6 92%

North America & Caribbean (NAC) 56.2 68.1 21%

South & Central America (SACA) 35.4 51.5 45%

South-East Asia (SEA) 106.9 184.5 73%

Western Pacific (WP) 215.4 253.8 18%

Source: International Diabetes Federation (IDF) Diabetes Atlas, 11th Edition, 2025.

Recent Developmental Activities in the Atherectomy Devices Market:

In January 2025, AngioDynamics also initiated a new clinical trial to further expand the system's indications for treating below-the-knee PAD.

January 2025, the FDA cleared the Rotarex(TM) Atherectomy System via a 510(k) substantial equivalence determination (K242757). This clearance was specifically for revised Instructions for Use (IFU) aimed at reducing helix breakage; no changes were made to the physical device itself.

In November 2024, Philips announced the enrollment of the first U.S. patient in a clinical trial for a combined laser atherectomy and intravascular lithotripsy catheter. This innovative, dual-function device is designed to simplify PAD treatment by integrating two therapies into a single procedure.

In September 2024, it received European CE Mark approval, allowing it to bring the solid-state laser technology to the European market for treating PAD, including critical limb ischemia and in-stent restenosis.

In April 2024, Avinger, Inc. received FDA 510(k) clearance for its Pantheris SV (Small Vessel) image-guided atherectomy system, a product line extension designed for smaller vessels.

In March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates.

In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.

Growth Drivers of the Global Atherectomy Devices Market

Rising Prevalence of Cardiovascular and Peripheral Artery Diseases

One of the major growth drivers of the global atherectomy devices market is the increasing prevalence of cardiovascular diseases (CVDs) and peripheral artery disease (PAD) worldwide. Factors such as aging populations, unhealthy lifestyles, smoking, obesity, hypertension, and diabetes are significantly contributing to the growing number of vascular disorders. Atherectomy devices are widely used to remove plaque buildup from blocked arteries and restore blood flow, especially in patients suffering from severe arterial calcification. The increasing burden of chronic diseases has created a higher demand for minimally invasive vascular procedures across hospitals and specialty clinics. In addition, the growing awareness regarding early diagnosis and treatment of arterial diseases is encouraging more patients to undergo interventional procedures. Healthcare providers are also focusing on advanced treatment methods that reduce complications and improve long-term outcomes. As a result, the rising incidence of vascular diseases continues to support the strong demand for atherectomy devices globally.

Growing Demand for Minimally Invasive Procedures

The increasing preference for minimally invasive surgical procedures is another key factor driving the growth of the atherectomy devices market. Patients and healthcare professionals are increasingly adopting catheter-based treatments because they offer several advantages over traditional open surgeries. Atherectomy procedures involve smaller incisions, reduced blood loss, shorter hospital stays, faster recovery times, and lower risks of post-operative complications. These benefits make atherectomy an attractive treatment option for elderly patients and individuals with multiple health conditions. In addition, advancements in imaging technologies and catheter designs have improved the precision and safety of atherectomy procedures. Healthcare systems worldwide are also focusing on reducing hospitalization costs and improving patient outcomes, which further supports the adoption of minimally invasive techniques. The growing availability of skilled interventional cardiologists and vascular surgeons has also contributed to the wider use of atherectomy devices. This increasing demand for efficient and less invasive treatment solutions continues to accelerate market growth globally.

Technological Advancements in Atherectomy Devices

Continuous technological innovation in atherectomy devices is playing a significant role in expanding the global market. Manufacturers are investing heavily in research and development activities to introduce advanced devices with improved safety, precision, and effectiveness. Modern atherectomy systems are equipped with enhanced imaging guidance, flexible catheter designs, and advanced plaque removal mechanisms that help physicians treat complex vascular lesions more efficiently. Technologies such as laser atherectomy, orbital atherectomy, and rotational atherectomy are gaining popularity due to their ability to treat heavily calcified arteries with minimal damage to surrounding tissues. In addition, the integration of digital imaging and artificial intelligence-based diagnostic tools is improving procedural accuracy and patient outcomes. Regulatory approvals for innovative products and increasing collaborations between medical device companies and healthcare institutions are further accelerating market expansion. These advancements are encouraging healthcare providers to adopt next-generation atherectomy devices, thereby supporting long-term growth in the global market.

Challenges of the Global Atherectomy Devices Market

High Cost of Atherectomy Procedures and Devices

One of the major challenges faced by the global atherectomy devices market is the high cost associated with atherectomy procedures and advanced medical devices. Atherectomy systems require sophisticated technologies, specialized catheters, and imaging equipment, which significantly increase treatment expenses. In many developing and underdeveloped countries, healthcare facilities may lack the financial resources to invest in advanced vascular intervention technologies. Additionally, patients without adequate health insurance coverage often face difficulties affording these procedures. The overall cost of treatment also includes hospital charges, physician fees, and post-operative care expenses, which can limit patient access to atherectomy procedures. Small healthcare centers may hesitate to adopt expensive devices due to budget constraints and uncertain reimbursement policies. Furthermore, pricing pressure in competitive healthcare markets can affect the profitability of manufacturers. These financial barriers may slow the adoption of atherectomy devices, especially in cost-sensitive regions, thereby limiting the overall growth potential of the global market.

Risk of Procedural Complications and Limited Skilled Professionals

Despite technological advancements, atherectomy procedures still carry certain clinical risks and complications that can restrict market growth. Potential complications such as vessel perforation, bleeding, embolization, arterial dissection, and restenosis may occur during or after the procedure. These risks can create concerns among patients and healthcare providers regarding the safety of atherectomy treatments. In addition, atherectomy procedures require highly skilled interventional cardiologists and vascular specialists who possess specialized training and experience. Many developing regions face a shortage of trained healthcare professionals capable of performing advanced vascular interventions effectively. The lack of skilled personnel can reduce procedural success rates and limit the adoption of atherectomy technologies in smaller healthcare facilities. Moreover, training programs and certification requirements for physicians can increase operational costs for hospitals. Concerns regarding patient safety, combined with the shortage of experienced specialists, remain significant challenges that may hinder the widespread expansion of the global atherectomy devices market.

Rotational Atherectomy Devices Market

The rotational atherectomy devices market is growing steadily due to the increasing prevalence of heavily calcified arterial blockages associated with cardiovascular diseases. Rotational atherectomy devices are specifically designed to remove hardened plaque deposits from arteries using a high-speed rotating burr, making them highly effective for complex vascular interventions. These devices are widely used in patients suffering from severe coronary artery disease and peripheral artery disease where traditional balloon angioplasty procedures may not provide effective outcomes. The rising aging population, growing incidence of diabetes, obesity, and high cholesterol are contributing significantly to the demand for advanced plaque modification technologies. In addition, healthcare providers are increasingly adopting rotational atherectomy systems because they improve blood flow restoration and support successful stent placement. Technological advancements in catheter flexibility, imaging systems, and procedural precision are also enhancing treatment success rates. As minimally invasive cardiovascular procedures continue to gain popularity worldwide, the demand for rotational atherectomy devices is expected to increase substantially during the forecast period.

Cardiovascular Atherectomy Devices Market

The cardiovascular atherectomy devices market is experiencing significant growth due to the increasing prevalence of cardiovascular disorders globally. Conditions such as coronary artery disease, peripheral artery disease, and atherosclerosis are becoming more common because of sedentary lifestyles, smoking, obesity, hypertension, and diabetes. Atherectomy devices are widely used to remove plaque buildup from arteries and restore proper blood circulation without the need for major surgery. The growing preference for minimally invasive procedures has increased the adoption of cardiovascular atherectomy systems in hospitals and specialty cardiovascular centers. In addition, advancements in medical imaging and catheter-based technologies have improved procedural accuracy and patient safety. Healthcare providers are increasingly focusing on reducing recovery times, minimizing surgical complications, and improving long-term cardiovascular outcomes, which further supports market growth. Rising healthcare expenditure, expanding awareness regarding early cardiovascular treatment, and continuous innovation in vascular intervention technologies are expected to drive the expansion of the cardiovascular atherectomy devices market globally.

Neurovascular Atherectomy Devices Market

The neurovascular atherectomy devices market is gaining attention due to the increasing prevalence of neurovascular disorders such as ischemic stroke, cerebral artery blockage, and other vascular abnormalities affecting the brain. Neurovascular atherectomy devices are designed to remove plaque and blockages from blood vessels supplying the brain, helping restore normal blood flow and reduce the risk of severe neurological complications. The growing aging population and rising incidence of hypertension, diabetes, and obesity are contributing to the higher occurrence of neurovascular diseases worldwide. In addition, increasing awareness regarding early stroke management and advancements in neurointerventional procedures are supporting the demand for these devices. Technological improvements in catheter navigation systems, imaging guidance, and minimally invasive surgical techniques are enhancing procedural efficiency and patient outcomes. Healthcare institutions are also investing in specialized neurovascular treatment centers to improve emergency stroke care. As demand for advanced neurological treatment solutions continues to rise, the neurovascular atherectomy devices market is expected to witness substantial growth in the coming years.

Atherectomy Devices Hospitals Market

Hospitals represent one of the largest end-user segments in the atherectomy devices market due to the increasing number of cardiovascular and peripheral vascular procedures performed globally. Hospitals are equipped with advanced medical infrastructure, specialized catheterization laboratories, and skilled healthcare professionals required for performing complex atherectomy treatments. The rising prevalence of peripheral artery disease, coronary artery disease, and other vascular disorders has significantly increased patient admissions for minimally invasive vascular interventions. Hospitals are increasingly adopting technologically advanced atherectomy systems to improve treatment accuracy, reduce procedural complications, and enhance patient recovery outcomes. In addition, favorable reimbursement policies and increasing healthcare investments are supporting the installation of modern vascular intervention technologies in hospitals worldwide. Large hospitals and multispecialty healthcare centers are also focusing on expanding cardiovascular treatment departments to meet growing patient demand. As the need for effective plaque removal procedures continues to increase, hospitals are expected to remain the dominant consumers of atherectomy devices during the forecast period.

United States Atherectomy Devices Market

The increasing elderly population in the United States is a major factor contributing to the growth of the atherectomy devices market. According to census data published in May 2023, the number of older adults in the country reached approximately 55.8 million, accounting for nearly 16.8% of the total population. Since peripheral artery disease (PAD) is more prevalent among aging individuals, the demand for atherectomy procedures and related devices continues to rise. In addition, the growing prevalence of chronic diseases such as atherosclerosis and PAD is further supporting market expansion. Conditions including obesity, diabetes, and high cholesterol significantly increase the risk of arterial blockages, often requiring atherectomy treatment. A May 2024 report from the CDC stated that nearly 25 million adults in the United States suffer from high cholesterol levels, increasing the likelihood of developing atherosclerosis. As cardiovascular diseases continue to rise, the demand for minimally invasive atherectomy procedures is expected to strengthen in the coming years.

Germany Atherectomy Devices Market

The Germany atherectomy devices market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD), among the aging population. Germany's advanced healthcare infrastructure and strong adoption of minimally invasive treatment procedures are supporting the increased use of atherectomy devices across hospitals and specialty clinics. In addition, growing awareness regarding early diagnosis and vascular disease management is encouraging patients to seek advanced treatment solutions. Favorable reimbursement policies and continuous technological innovations in atherectomy systems are further accelerating market growth. The rising incidence of lifestyle-related conditions such as obesity, diabetes, and high cholesterol is also contributing to the growing burden of arterial diseases in the country. As healthcare providers increasingly focus on effective and less invasive treatment options, the demand for atherectomy devices is expected to continue expanding throughout Germany over the forecast period.

India Atherectomy Devices Market

The atherectomy devices market in India is experiencing considerable growth due to the increasing burden of cardiovascular diseases, especially peripheral artery disease (PAD), among the country's large population base. Rising cases of diabetes, obesity, hypertension, and high cholesterol are contributing to a greater incidence of arterial blockages, thereby increasing the demand for atherectomy procedures. In addition, the rapidly growing elderly population is creating higher demand for advanced vascular treatment solutions. India's expanding healthcare infrastructure, increasing healthcare expenditure, and improving access to modern medical technologies are supporting market development. Greater awareness regarding minimally invasive procedures among both healthcare professionals and patients is also encouraging the adoption of atherectomy devices. Furthermore, favorable government initiatives aimed at improving healthcare accessibility, along with ongoing technological advancements in vascular intervention devices, are expected to further boost market growth in India during the forecast period.

Saudi Arabia Atherectomy Devices Market

The Saudi Arabia atherectomy devices market is growing steadily due to the rising prevalence of cardiovascular disorders, particularly peripheral artery disease (PAD), among the aging population. Increasing lifestyle-related health conditions such as diabetes, obesity, and high cholesterol are significantly contributing to the growing number of arterial disease cases in the country. The demand for minimally invasive treatment procedures is increasing as patients and healthcare providers seek safer and more efficient alternatives to traditional surgeries. In addition, ongoing improvements in healthcare infrastructure and rising investments in advanced medical technologies are supporting the wider adoption of atherectomy devices across Saudi Arabia. Government initiatives focused on strengthening the healthcare sector and improving patient access to modern treatment options are also contributing to market growth. Technological advancements in atherectomy systems, combined with increasing awareness regarding vascular disease management, are expected to drive further expansion of the market in the coming years.

Atherectomy Devices Market Segmentation

Product Type

• Directional
• Rotational
• Orbital
• Laser

Application

• Cardiovascular
• Neurovascular
• Peripheral Vascular

End User

• Hospitals
• Ambulatory Care Service
• Medical Research Institutes

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

Rest of the World

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Boston Scientific Corporation, Inc.
• Abbott Laboratories
• Medtronic plc
• Cardinal Health
• Terumo Corporation
• Integer Holdings Corporation
• Becton, Dickinson and Company
• AngioDynamics Inc.